Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. Fresenius Kabi announced the launch of Adenosine ...

IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday. Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV ...

SCHAUMBURG -- Sagent Pharmaceuticals Inc., a privately-held specialty pharmaceutical company, said Thursday it has launched a line of pre-filled, ready-to-use, 6 mg and 12 mg adenosine syringes.

SCHAUMBURG, Ill., Nov. 29 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company today announced that it haslaunched a full-line of prefilled, ready-to-use, 6 mg and 12 mg ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.

Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...

The global Adenosine Injection market size is projected to gain market growth of ($ XX Mn), and it is estimated to reach $ XX Mn with a CAGR rate of XX% in the forecast period 2021-2030. Let’s grow ...